ARTICLE | Clinical News
Antisoma, Archemix preclinical data
April 14, 2008 7:00 AM UTC
Data published in Cancer Research showed that a 5 µmol/L dose of AS1411 inhibited breast cancer cell growth while a 4-fold higher dose had no discernible effects on normal breast cells. The anti- nucl...